Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 60c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.58), $0.60 better than the analyst estimate of ($1.18).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
• Braze stock tumbles 10% on weak third quarter EPS guidance